Calreticulin Regulates VEGF-A in Neuroblastoma Cells

Molecular Neurobiology

Volumn 52, Issue 1, 2015, Pages 758-770

  Weng, Wen Chin ^a,b   Lin, Kuan Hung ^b   Wu, Pei Yi ^b   Lu, Yi Chien ^b   Weng, Yi Cheng ^b   Wang, Bo Jeng ^c   Liao, Yung Feng ^c   Hsu, Wen Ming ^a   Lee, Wang Tso ^a   Lee, Hsinyu ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Calreticulin; Neuroblastoma; Neuronal differentiation; VEGF

Indexed keywords

CALRETICULIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MOLECULAR MARKER; NEUROMODULIN; PROTEIN TYROSINE KINASE A; TETRACYCLINE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; BIOLOGICAL MARKER; CALRETICULIN, HUMAN; SMALL INTERFERING RNA; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NEUROBLASTOMA CELL LINE; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR BLOCKING; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NERVE CELL; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BIOMARKERS; CALRETICULIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEUROBLASTOMA; NEURONS; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84937968054     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8901-8     Document Type: Article

References (39)

1. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3):203–216. doi:10.1038/nrc1014
2. Chang HH, Hsu WM (2010) Neuroblastoma—a model disease for childhood cancer. J Formos Med Assoc 109(8):555–557
3. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369(9579):2106–2120. doi:10.1016/s0140-6736(07)60983-0
4. Israel MA (1993) Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma. Cancer 71(10 Suppl):3310–3313
5. Ijiri R, Tanaka Y, Kato K, Misugi K, Nishihira H, Toyoda Y, Kigasawa H, Nishi T, Takeuchi M, Aida N, Momoi T (2000) Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression. Am J Surg Pathol 24(6):807–815
6. Nishihira H, Toyoda Y, Tanaka Y, Ijiri R, Aida N, Takeuchi M, Ohnuma K, Kigasawa H, Kato K, Nishi T (2000) Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution. J Clin Oncol 18(16):3012–3017
7. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328(12):847–854. doi:10.1056/nejm199303253281205
8. Hoehner JC, Gestblom C, Olsen L, Pahlman S (1997) Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma. Br J Cancer 75(8):1185–1194
9. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M (1999) Calreticulin: one protein, one gene, many functions. Biochem J 344(Pt 2):281–292
10. Lu YC, Chen CN, Wang B, Hsu WM, Chen ST, Chang KJ, Chang CC, Lee H (2011) Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression. Am J Pathol 179(3):1425–1433. doi:10.1016/j.ajpath.2011.05.015
11. Xiao G, Chung TF, Pyun HY, Fine RE, Johnson RJ (1999) KDEL proteins are found on the surface of NG108-15 cells. Brain Res Mol Brain Res 72(2):121–128
12. Xiao G, Chung TF, Fine RE, Johnson RJ (1999) Calreticulin is transported to the surface of NG108-15 cells where it forms surface patches and is partially degraded in an acidic compartment. J Neurosci Res 58(5):652–662
13. Johnson RJ, Liu N, Shanmugaratnam J, Fine RE (1998) Increased calreticulin stability in differentiated NG-108-15 cells correlates with resistance to apoptosis induced by antisense treatment. Brain Res Mol Brain Res 53(1–2):104–111
14. Hsu WM, Hsieh FJ, Jeng YM, Kuo ML, Chen CN, Lai DM, Hsieh LJ, Wang BT, Tsao PN, Lee H, Lin MT, Lai HS, Chen WJ (2005) Calreticulin expression in neuroblastoma—a novel independent prognostic factor. Ann Oncol 16(2):314–321. doi:10.1093/annonc/mdi062
15. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669–676. doi:10.1038/nm0603-669
16. George ML, Tutton MG, Janssen F, Arnaoutz A, Abulafi AM, Eccles SA, Swift RI (2001) VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3(5):420–427. doi:10.1038/sj.neo.7900186
17. Bäckman U, Svensson Å, Christofferson R (2002) Importance of vascular endothelial growth factor A in the progression of experimental neuroblastoma. Angiogenesis 5(4):267–274. doi:10.1023/A:1024564817563
18. Fakhari M, Pullirsch D, Paya K, Abraham D, Hofbauer R, Aharinejad S (2002) Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma. J Pediatr Surg 37(4):582–587. doi:10.1053/jpsu.2002.31614
19. Becker J, Pavlakovic H, Ludewig F, Wilting F, Weich HA, Albuquerque R, Ambati J, Wilting J (2010) Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 16(5):1431–1441. doi:10.1158/1078-0432.CCR-09-1936
20. Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, Hsieh FJ, Lee PH, Kuo ML, Lee H, Chang KJ (2009) Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer. Ann Surg Oncol 16(2):524–533. doi:10.1245/s10434-008-0243-1
21. Porebska I, Wyrodek E, Kosacka M, Adamiak J, Jankowska R, Harlozinska-Szmyrka A (2006) Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. In Vivo 20(5):599–604
22. Puppo M, Battaglia F, Ottaviano C, Delfino S, Ribatti D, Varesio L, Bosco MC (2008) Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha. Mol Cancer Ther 7(7):1974–1984. doi:10.1158/1535-7163.mct-07-2059
23. Fiore G, Ghelardini C, Bruni G, Guarna M, Bianchi E (2013) Differentiation state affects morphine induced cell regulation in neuroblastoma cultured cells. Neurosci Lett 555:51–56. doi:10.1016/j.neulet.2013.07.039
24. Peterson S, Bogenmann E (2004) The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation. Oncogene 23(1):213–225. doi:10.1038/sj.onc.1206980
25. Pike SE, Yao L, Jones KD, Cherney B, Appella E, Sakaguchi K, Nakhasi H, Teruya-Feldstein J, Wirth P, Gupta G, Tosato G (1998) Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth. J Exp Med 188(12):2349–2356. doi:10.1084/jem.188.12.2349
26. Pike SE, Yao L, Setsuda J, Jones KD, Cherney B, Appella E, Sakaguchi K, Nakhasi H, Atreya CD, Teruya-Feldstein J, Wirth P, Gupta G, Tosato G (1999) Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 94(7):2461–2468
27. Ribatti D, Marimpietri D, Pastorino F, Brignole C, Nico B, Vacca A, Ponzoni M (2004) Angiogenesis in neuroblastoma. Ann N Y Acad Sci 1028:133–142. doi:10.1196/annals.1322.014
28. Ribatti D, Vacca A, Nico B, De Falco G, Giuseppe Montaldo P, Ponzoni M (2002) Angiogenesis and anti-angiogenesis in neuroblastoma. Eur J Cancer 38(6):750–757
29. Rossler J, Taylor M, Geoerger B, Farace F, Lagodny J, Peschka-Suss R, Niemeyer CM, Vassal G (2008) Angiogenesis as a target in neuroblastoma. Eur J Cancer 44(12):1645–1656. doi:10.1016/j.ejca.2008.05.015
30. Cañete A, Navarro S, Bermúdez J, Pellín A, Castel V, Llombart-Bosch A (2000) Angiogenesis in neuroblastoma: Relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J Clin Oncol 18(1):27–34
31. Kim E, Moore J, Huang J, Soffer S, Manley CA, O'Toole K, Middlesworth W, Stolar CJ, Kandel JJ, Yamashiro DJ (2001) All angiogenesis is not the same: distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. J Pediatr Surg 36(2):287–290. doi:10.1053/jpsu.2001.20691
32. Poliani PL, Mitola S, Ravanini M, Ferrari-Toninelli G, D'Ippolito C, Notarangelo LD, Bercich L, Wagener C, Memo M, Presta M, Facchetti F (2007) CEACAMI/VEGF cross-talk during neuroblastic tumour differentiation. J Pathol 211(5):541–549. doi:10.1002/path.2135
33. Dungwa JV, Hunt LP, Ramani P (2012) HIF-1alpha up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas. Histopathology 61(3):417–427. doi:10.1111/j.1365-2559.2012.04227.x
34. Mackenzie F, Ruhrberg C (2012) Diverse roles for VEGF-A in the nervous system. Development 139(8):1371–1380. doi:10.1242/dev.072348
35. Carmeliet P, De Almodovar CR (2013) VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration. Cell Mol Life Sci 70(10):1763–1778. doi:10.1007/s00018-013-1283-7
36. Meng H, Zhang Z, Zhang R, Liu X, Wang L, Robin AM, Chopp M (2006) Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors. Neurosci Lett 393(2–3):97–101. doi:10.1016/j.neulet.2005.09.044
37. Chen J, Zacharek A, Li A, Zhang C, Ding J, Roberts C, Lu M, Kapke A, Chopp M (2006) Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder rats. Neuroscience 141(2):737–744. doi:10.1016/j.neuroscience.2006.04.042
38. Genetos DC, Cheung WK, Decaris ML, Leach JK (2010) Oxygen tension modulates neurite outgrowth in PC12 cells through a mechanism involving HIF and VEGF. J Mol Neurosci 40(3):360–366. doi:10.1007/s12031-009-9326-0
39. Li Y, Luo J, Lau WM, Zheng G, Fu S, Wang TT, Zeng HP, So KF, Chung SK, Tong Y, Liu K, Shen J (2011) Caveolin-1 plays a crucial role in inhibiting neuronal differentiation of neural stem/progenitor cells via VEGF signaling-dependent pathway. PLoS One 6(8):e22901. doi:10.1371/journal.pone.0022901